Thorne Healthtech, Inc. (THRN): Price and Financial Metrics

Thorne Healthtech, Inc. (THRN): $4.47

0.32 (+7.71%)

POWR Rating

Component Grades













Add THRN to Watchlist
Sign Up

Industry: Food Makers



in industry


  • THRN scores best on the Growth dimension, with a Growth rank ahead of 95.45% of US stocks.
  • The strongest trend for THRN is in Growth, which has been heading up over the past 177 days.
  • THRN's current lowest rank is in the Momentum metric (where it is better than 49.08% of US stocks).

THRN Stock Summary

  • With a one year PEG ratio of 0.47, THORNE HEALTHTECH INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 4.24% of US stocks.
  • THORNE HEALTHTECH INC's stock had its IPO on September 23, 2021, making it an older stock than just 2.09% of US equities in our set.
  • With a year-over-year growth in debt of -40.18%, THORNE HEALTHTECH INC's debt growth rate surpasses just 7.5% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to THORNE HEALTHTECH INC, a group of peers worth examining would be HNST, INMD, CDXC, STIM, and PLAG.
  • To check out THORNE HEALTHTECH INC's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001844280.

THRN Valuation Summary

  • THRN's price/sales ratio is 0.9; this is 52.63% lower than that of the median Consumer Defensive stock.
  • THRN's EV/EBIT ratio has moved up 250.5 over the prior 16 months.

Below are key valuation metrics over time for THRN.

Stock Date P/S P/B P/E EV/EBIT
THRN 2023-01-18 0.9 1.4 29.2 36.0
THRN 2023-01-17 0.9 1.5 30.4 37.4
THRN 2023-01-13 0.9 1.5 30.5 37.5
THRN 2023-01-12 0.9 1.5 29.7 36.6
THRN 2023-01-11 0.9 1.5 29.7 36.5
THRN 2023-01-10 0.9 1.5 30.2 37.1

THRN Stock Price Chart Interactive Chart >

Price chart for THRN

THRN Price/Volume Stats

Current price $4.47 52-week high $7.38
Prev. close $4.15 52-week low $3.41
Day low $4.09 Volume 79,000
Day high $4.54 Avg. volume 55,883
50-day MA $4.06 Dividend yield N/A
200-day MA $5.00 Market Cap 236.20M

Thorne Healthtech, Inc. (THRN) Company Bio

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

THRN Latest News Stream

Event/Time News Detail
Loading, please wait...

THRN Latest Social Stream

Loading social stream, please wait...

View Full THRN Social Stream

Latest THRN News From Around the Web

Below are the latest news stories about THORNE HEALTHTECH INC that investors may wish to consider to help them evaluate THRN as an investment opportunity.

13 Cheap New Stocks To Buy

In this article, we will take a look at the 13 cheap new stocks to buy. To see more such companies, go directly to 5 Cheap New Stocks To Buy. Global markets were rattled by the market crash of 2022 whose reverberations are expected to affect equities for several months to come. However, prudent investors […]

Yahoo | January 22, 2023

While individual investors own 18% of Thorne HealthTech, Inc. (NASDAQ:THRN), public companies are its largest shareholders with 59% ownership

Every investor in Thorne HealthTech, Inc. ( NASDAQ:THRN ) should be aware of the most powerful shareholder groups. The...

Yahoo | January 11, 2023

U.S. Appeals Court Issues Final Ruling That Upholds Thorne HealthTech Inc.'s Prior Challenge of Nicotinamide Riboside Intellectual Property Claim

On January 3, 2023, the U.S. Circuit Court of Appeals for the Federal Circuit in Washington, D.C., issued a final ruling rendering the previously issued U.S. Patent No. 8,383,086 ("the '086 patent") to be unpatentable and therefore invalid. The '086 patent claim covered "The pharmaceutical composition . . . wherein nicotinamide riboside is isolated from a natural or synthetic source." The effect of the '086 patent was to provide broad patent protection of the nicotinamide riboside (NR) molecule

Yahoo | January 9, 2023

Should We Be Cautious About Thorne HealthTech, Inc.'s (NASDAQ:THRN) ROE Of 3.1%?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Yahoo | December 22, 2022

Thorne HealthTech (NASDAQ:THRN) Might Have The Makings Of A Multi-Bagger

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Yahoo | December 1, 2022

Read More 'THRN' Stories Here

THRN Price Returns

1-mo 24.51%
3-mo -12.18%
6-mo -13.04%
1-year -8.78%
3-year N/A
5-year N/A
YTD 23.14%
2022 -41.55%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7846 seconds.